Quotient Therapeutics

Quotient Therapeutics is a biotechnology company developing medicines from genetic differences between cells within the same person.

Its somatic genomics platform combines sensitive DNA sequencing, cell analysis and computational biology to identify mutations linked to disease resistance or susceptibility. These naturally occurring changes reveal drug targets and inform therapeutic design.

Its internal drug discovery focuses on autoimmune disease, with partnered research spanning cardiovascular, respiratory, liver and inflammatory bowel diseases.